Dublin, April 24, 2023 (GLOBE NEWSWIRE) -- The "Global Antimicrobial Susceptibility Testing Market Size, Share & Industry Trends Analysis Report by Application, Method, Type, End User, Product, Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.
The Global Antimicrobial Susceptibility Testing Market size is expected to reach $4.9 billion by 2028, rising at a market growth of 5.9% CAGR during the forecast period.
Key Market Players
List of Companies Profiled in the Report:
- BioMerieux S.A.
- Becton, Dickinson and Company
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- Bruker Corporation
- Accelerate Diagnostics, Inc.
- HiMedia Laboratories Pvt. Ltd.
- F. Hoffmann-La Roche Ltd.
Antimicrobial susceptibility testing (AST) is a technique used to determine which antimicrobials a particular organism or organism group is resistant to. Susceptibility arises when microorganisms like fungi and bacteria cannot survive with one or more antimicrobial drugs. It is a laboratory technique to determine which antimicrobial treatment is most effective against microorganisms. In addition, it is used to determine which antibiotic inhibits the growth of bacteria, fungi, and other pathogens that cause illness.
After microorganisms that cause illness, like fungi, bacteria, and viruses, have been isolated from a culture of the specimen, susceptibility testing is conducted on them. Antimicrobial susceptibility testing (AST) is performed to examine the potential effectiveness of different antibiotics on bacteria and/or whether bacteria have developed resistance to particular antibiotics, along with antifungal or antiviral species. The findings of this test may be employed to select the medication(s) most likely to efficiently treat a disease. They have access to antibiotics.
AST contributes to evaluating treatment services offered by hospitals, clinics, and governmental programs to control and prevent infectious diseases. The testing determines the sensitivity of a bacterial, fungal, or viral strain to a panel of antifungals, antibiotics, and antivirals. In addition, the test examines if the bacterium can grow in the presence of these antimicrobials by exposing it to them. This information is provided to physicians in the form of the Minimum Inhibitory Concentration (MIC), which measures the susceptibility or resistance of a bacteria to an antibiotic.
The demand for antimicrobial susceptibility testing has increased due to infectious disease outbreaks like Shigella, Neisseria gonorrhoeae, Neisseria meningitides, and Salmonella serotype typhi, which has been attributed to a lack of water supply, sanitation, and hygiene. As a result, physicians have recognized the importance of antibiotic susceptibility tests (ASTs), which are now a necessary part of clinical microbiology laboratories and are expected to boost the market.
Market Growth Factors
Growing research activities to develop rapid antimicrobial susceptibility testing
The rapid growth of multidrug-resistant microbial diseases has forced researchers to gain a thorough understanding of how microbial infections occur, as well as to create novel diagnostic tools and antimicrobials. To determine the best antibiotic to use against a microbe, the sensible use of large-range antimicrobial medicines necessitates a quick and sensitive diagnostic technique. It can take up to 1 to 3 days to complete an antimicrobial susceptibility test (AST) using the most current technology.
Increasing infectious disease caused by bacteria & fungus and growing microbial resistance
Government funding and interest are two other aspects that significantly impact the development of the goal product. For instance, the World Health Organization (WHO) and other non-profit funding organizations suggested an innovative antimicrobial innovation funding mechanism in which the government would fund grants and innovation-induced rewards which would benefit upstream innovation, interim trial findings, and final product outcomes. As a result, the market for antimicrobial susceptibility testing is anticipated to expand due to these factors.
Market Restraining Factor
Restrictions associated with antimicrobial susceptibility testing
Even though AST has become a vital aspect of clinical diagnostics and drug discovery & development, the market expansion could be hampered by some constraints. For instance, the three most frequent in-vitro tests for antimicrobial susceptibility, agar dilution, disk diffusion, and broth dilution, determine the MIC of an antimicrobial agent.
In addition, there are lengthy lags between the update of a clinical breakpoint and its approval on commercial antimicrobial susceptibility testing (cAST) devices, which can endanger patient safety because laboratories may fail to detect medication resistance.
Scope of the Study
By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Epidemiology & Others
By Method
- Automated Susceptibility Testing Instruments
- Disk Diffusion
- Etest Method
- Agar Diffusion
- Genotyping Method
By Type
- Antibacterial
- Antifungal
- Antiparasitic
- Others
By End-user
- Hospitals & Diagnostic centers
- Pharmaceutical & Biotechnology Companies
- Research & Academic Institutes
- Clinical Research Organizations
By Product
- Automated Laboratory Instruments
- Manual Laboratory Instruments
- Culture & Growth Media
- Consumables
For more information about this report visit https://www.researchandmarkets.com/r/w5hr06
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
